Transgenomic, Inc. Reports Third Quarter 2014 Financial Results
Transgenomic, Inc. (NASDAQ:TBIO) today reported financial results for the third quarter ended September 30, 2014, and provided a business update.
Third Quarter Financial Results
Net sales for the third quarter of 2014 were $6.4 million compared with $6.6 million for the same period in 2013. Importantly, the core Laboratory Services segment continued its trend of sequential quarter-over-quarter sales growth for the third consecutive quarter.
Help employers find you! Check out all the jobs and post your resume.
Third Quarter Financial Results
Net sales for the third quarter of 2014 were $6.4 million compared with $6.6 million for the same period in 2013. Importantly, the core Laboratory Services segment continued its trend of sequential quarter-over-quarter sales growth for the third consecutive quarter.
Help employers find you! Check out all the jobs and post your resume.